CIK: 1563623 - Address: C/O Athira Pharma, Inc., 18706 North Creek Parkway, Suite 104, Bothell, WA 98011
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret114-347-1-16-49-9
P%wins7575752525046

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/5/24 19:51
9/5/24
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagGengos AndrewWAOCFO,CHIES-10.56600-1-198D
2/16/24 16:34
1/5/24
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagGengos AndrewWAOCFO,CHIES.a-42.910-1-184D
1/8/24 16:42
1/5/23
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagGengos AndrewWAOSee BeloS-42.910-1-184D
6/9/23 17:06
6/7/23
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagGengos AndrewWAOSee BeloP513.430152380D
6/6/23 19:36
6/2/23
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagGengos AndrewWAOSee BeloP.m1922.95065New65D
12/2/15 19:43
11/30/15
IMUCImmunocellular Therapeutics, Ltd.DEHealthDrugPharmaceutical PreparationsGengos AndrewCADOP,CEOP40.43500104238I-87-39-14-205-17-40-5-14-28-42-81
2/20/15 18:36
2/18/15
IMUCImmunocellular Therapeutics, Ltd.DEHealthDrugPharmaceutical PreparationsGengos AndrewCADOP,CEOP.d250.600004111278D-79-56-38-10-23-19-224252-9-27-57
8/14/14 17:38
8/14/14
IMUCImmunocellular Therapeutics, Ltd.DEHealthDrugPharmaceutical PreparationsGengos AndrewCADOP,CEOP90.89940103737D-70-69-25-24-19-6-1-1013-35-36-46
12/18/13 12:49
12/18/13
IMUCImmunocellular Therapeutics, Ltd.DEHealthDrugPharmaceutical PreparationsGengos AndrewCADOP,CEOP190.7171027New27D-39-59-62-69-68-75-71-24-1215387043-10

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact